Study Finds Secondhand Smoke May Raise Breast Cancer Risk
Posted on: Saturday, 12 March 2005, 06:00 CST
A sweeping new study on the health risks of breathing secondhand smoke adds breast cancer and premature birth to an already long list of ills associated with cigarettes.
The findings, which go further in establishing the link between cigarettes and breast cancer than any before, are sure to be debated for months. But the draft study already has spurred discussion in the nation about regulating tobacco use in private venues such as cars.
"It's another indictment of tobacco and the health effects of secondhand smoke on healthy people, especially children," said Paul Knepprath, vice president for government relations with the American Lung Association of California.
"It provides an opportunity for California to continue its leadership in reducing exposure to the public."
The analysis was conducted by scientists at the Office of Environmental Health Hazard Assessment, a respected research arm of the California Environmental Protection Agency. The team considered the results of about 1,000 studies to come up with its conclusions.
The newest, most attention-getting finding is that exposure to secondhand smoke may increase a woman's risk of breast cancer nearly twofold. Though several earlier studies found no such link, the researchers said that recent and better-controlled studies consistently identified elevated risk, particularly in younger women.
"What this really does say is that tobacco smoke is a risk factor for breast cancer," said Melanie Marty, who led the team.
Oddly enough, smoking itself is not thought to elevate breast cancer risk. Marty said that may be because active smoking reduces levels of estrogen, a hormone in the body that fuels tumor growth.
"We think that partially mitigates the risk and confuses the picture," she said.
Inhaling smoke secondhand, however, may not significantly dampen estrogen levels.
Evidence of a link between breast cancer and tobacco was strongest among younger, pre-menopausal women.
Dr. Scott Christensen, associate clinical professor of oncology at the University of California, Davis Medical Center, was not surprised. He said that during a woman's menstrual cycle, hormones cause cells to grow and divide, making their DNA more susceptible to cancer-causing damage.
On average, women in the United States have a one in eight chance of developing breast cancer.
"It's a complex disease, with lots of factors," Marty said. "This is just one of the factors."
In addition to identifying an elevated risk for breast cancer, state scientists found that exposure to secondhand smoke raises by 50 percent to 80 percent the risk of premature birth.
Marty said scientists previously had associated passive smoking with low-birth-weight babies, but the finding about premature birth is new.
Source: Seattle Post - Intelligencer
Related Articles
- Video from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
- News from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
- Breast Cancer Will Risk Increases For Smokers and Overweight Women
- Pelosi Statement on President Obama Signing Smoking Prevention and Tobacco Control Act
- Statement by American Heart Association CEO Nancy Brown on Senate Passage of the Family Smoking Prevention and Tobacco Control Act June 11, 2009
- UST Inc. Comments on Introduction of Family Smoking Prevention and Tobacco Control Act
- St. Louis Cancer & Breast Institute Physician Says Hormone Replacement Therapy Does Indeed Create Breast Cancer Risk
- Study shows radiation therapy for pelvic cancers increases risk for fractures in older women
- HEALTH: 10 FACTS YOU SHOULD KNOW ABOUT BEATING BREAST CANCER ; Breast Cancer is Estimated to Affect One in Nine Women in Britain. Luckily, There Have Been Huge Developments in Treatments Available Heres a Look at What the Future Holds for the Fight Again
- Spectrum Pharmaceuticals Presents Data on SPI-1620 at the Annual Meeting of the American Association of Cancer Research (AACR), in Anaheim, California
User Comments (0)

RSS Feeds